Senior Director of Program Operations, Sara Rothschild, recently represented the Life Raft Group at the SPAEN (Sarcoma Patients EuroNet) meeting. Subsequent to the meeting, over 300 medical professionals gathered for the 7th annual ESMO (European Society for Medical Oncology) Sarcoma and GIST Conference. in Milan, Italy. Over 50 delegates gathered from Europe, US and India […]
ESMO, GIST research, Global, Sarcoma Research, SPAEN
The Life Raft Group had the pleasure of hosting the global New Horizons GIST meeting this year in our Wayne, New Jersey office. This international meeting traditionally gathers global GIST advocates with the shared vision to unify and support patient advocacy efforts and hear advances in research and treatment of GIST. 31 participants from 15 […]
Amy Bruno-Lindner, Blueprint Medicines, Contactgroep GIST, Dana Farber Cancer Institute, David Josephy, Dr. Bill Tap, Dr. Carl Asche, Dr. Ciara Kelly, Dr. Suzanne George, Dr. Theresa Mullin, Fundación GIST México, Gerard van Oortmerssen, Ginger Sawyer, GIST Support International, GIST Support Osterreich, Markus Wartenberg, Martin Wettstein, Memorial Sloan-Kettering Cancer Center, New Horizons, NewHorizons2017, Novartis, Pat Garcia, Pfizer, Piga Fernandex, Rodrigo Salas, The Max Foundation
By Malcolm Sutherland Life Raft Group Canada (LRGC) held its 6th Annual GIST Day of Learning on October 21, 2-17 in Toronto. Topics Topics included: “Highlights from New Horizons GIST Conference”, presented by LRGC President David Josephy “Patient Self-Advocacy: An Approach to Getting the Best GIST Care”, co-presented by Laetitia Tam, LRGC Director and Liz […]
Alia Tawer, David Josephy, Dr. Albi Razak, GDOL, GIST Sarcoma Life Raft Group Canada, Laetitia Tam, Liz Aguiar
The GIST Group Switzerland, the support group for patients with gastrointestinal stromal tumor (GIST) has awarded its science prize for the eighth time. The 2017 GIST prize, worth CHF 10,000, was awarded to Dr. Adrian Siefert of the University Hospital, TU, Dresden, Germany for his publication on “PD-1/PD-L1 Blockade Enhances T-Cell Activity and Antitumor Efficacy […]
Dr. Adrian Siefert, Dr. Michael Montemurro, GIST Group Switzerland, Journal of Clinical Cancer Research, SAAK, University Hospital Dresden Germany